6,544 followers
New research: Outcomes of Anlotinib Maintenance Therapy in Patients With Advanced NSCLC in a Real-World Setting: Background Anlotinib is a novel tyrosine kinase inhibitor with promising anti-tumor activity in patients with advanced non-small… https://t.co